Skip to main content
International Journal of Nanomedicine logoLink to International Journal of Nanomedicine
. 2026 Nov 9;21:643508. doi: 10.2147/IJN.S643508

Injectable Nanozyme–Polyphenol GelMA Hydrogel for Mitochondrial Immunomodulation and Periodontal Bone Protection: An in vitro and in vivo Study

Jiayu Lin 1,*, Yueshan Zhou 1,*, Hourong Lai 2, Zhihao Liao 1, Liqin Zheng 3,✉, Xiuhong Huang 4,✉
PMCID: PMC13762449  PMID: 43032729

Abstract

Purpose

Periodontitis involves persistent oxidative stress, mitochondrial dysfunction, and dysregulated macrophage activation. This study aimed to develop and evaluate an injectable nanozyme–polyphenol GelMA hydrogel (TCM-Gel) for local periodontal therapy.

Methods

TCM-Gel was characterized for physicochemical, antioxidant, and catalase-like properties. Its effects on macrophage mitochondrial indices, inflammatory phenotype, and human gingival fibroblast responses were evaluated in vitro using three independent biological replicates. A ligature-induced mouse periodontitis model included healthy control, Ligature + PBS, and Ligature + TCM-Gel groups (n = 5 mice per group), and local tissue response was assessed in 3 mice.

Results

TCM-Gel formed a porous, mechanically resilient hydrogel with pH-dependent component availability, radical-scavenging activity, and catalase-like H2O2 decomposition. In LPS-challenged macrophages, TCM-Gel increased the CD206/CD80 ratio (~1.85, P < 0.001), increased the JC-1 red/green ratio (~6.7) compared with the control (~3.2) and GSH (~4.2) groups, reduced intracellular ROS (~8% vs ~95% in the H2O2 positive control, P < 0.001), and increased CAT activity (~5.1 vs ~2.3 in the control group, P < 0.001). SIRT1, SDHB, UQCRC2, and ATP5A transcript levels increased by approximately 5.2-, 2.7-, 2.9-, and 7.2-fold, respectively (all P < 0.001). In hGFs, TCM-Gel attenuated ferroptosis-associated marker changes, including reduced p53 and ACSL4 and increased GPX4 levels (all P < 0.001), and improved mineralization and osteogenic marker expression. In vivo, TCM-Gel reduced inflammatory infiltration, osteoclast activity, and alveolar bone loss, and increased CD206, endomucin, and SIRT1 immunoreactivity. Micro-computed tomography showed that BV/TV increased from 19.10 ± 2.47% in the Ligature + PBS group to 25.42 ± 0.44% in the TCM-Gel group.

Conclusion

TCM-Gel was associated with improved redox status, macrophage mitochondrial indices, pro-resolving macrophage-marker expression, and periodontal bone preservation. These findings support further evaluation of this nanozyme–polyphenol hydrogel as a local periodontal nanomedicine platform.

Keywords: chitosan oligosaccharide, molybdate nanocomplex, immunometabolism, oxidative stress, local delivery, periodontitis

Introduction

Periodontitis is a chronic inflammatory disease initiated by plaque dysbiosis and amplified by a dysregulated host response. It progressively destroys the periodontal supporting apparatus, remains a major cause of tooth loss, and is associated with systemic disorders including diabetes and cardiovascular disease.1–4 Mechanical debridement remains the foundation of periodontal treatment, but reducing the microbial burden alone may not fully resolve the persistent oxidative, immune, and tissue-repair disturbances that drive periodontal destruction and disease recurrence.5 The periodontal pocket is a wet, dynamic, and locally heterogeneous site in which soluble agents can be diluted or cleared rapidly. Existing biomaterial approaches have often emphasized antimicrobial activity, antioxidant protection, or a single immunoregulatory cue; a platform that combines local retention with coordinated redox and macrophage immunometabolic regulation remains needed. Biomaterials capable of local retention and controlled regulation of the periodontal immune microenvironment may therefore complement conventional therapy by addressing interacting pathological processes at the disease site.

The pH of gingival crevicular fluid and periodontal pockets is not fixed and may vary with sampling site, inflammatory status, fluid flow, and local microbial metabolism. It is therefore more appropriate to regard periodontal pH as a dynamic and spatially heterogeneous microenvironmental feature rather than as a universally acidic or alkaline condition. Recent periodontal biomaterial studies have incorporated pH-responsive designs to improve the adaptability of local therapeutic systems.6,7 Accordingly, the pH-dependent behavior of TCM-Gel was investigated under defined in vitro conditions to evaluate its responsiveness to changes in the surrounding microenvironment.

Macrophages are central regulators of periodontal inflammation and repair.8,9 Pro-inflammatory macrophage states contribute to cytokine and reactive oxygen species production, whereas pro-resolving states support inflammatory resolution and tissue repair. Although this behavior is often described using an M1/M2 framework, macrophage activation exists along a functional spectrum. Current immunomodulatory approaches remain limited by local delivery, phenotypic stability, and insufficient control of the metabolic basis of macrophage dysfunction.10–12 Persistent oxidative stress can impair mitochondrial dynamics and quality control, leading to accumulation of dysfunctional mitochondria and restricting the oxidative metabolic programs required for pro-resolving macrophage functions.13,14 Restoring mitochondrial homeostasis may therefore provide an upstream route to interrupt the oxidative stress-mitochondrial dysfunction-inflammatory activation cycle.

Among mitochondria-directed approaches, molybdenum-containing materials have emerged as potential immunometabolic modulators. Molybdenum-associated cues have been reported to increase expression of genes involved in mitochondrial biogenesis and support respiratory-chain activity and ATP production.15 A chitosan oligosaccharide-molybdate system was further reported to preferentially improve the metabolic state of dysfunctional macrophages and promote a shift from glycolysis toward oxidative phosphorylation, with comparatively limited effects on unstressed cells.16 Recent periodontal biomaterial studies have also explored oxygen-generating and microenvironment-responsive hydrogel strategies,6,7,17 while multifunctional molybdenum-containing platforms for periodontal immunometabolic regulation remain less explored. Chitosan oligosaccharide (COS) is a low-molecular-weight, amino-rich chitosan derivative with antioxidant and immunomodulatory activity.18,19 Its protonatable amino groups can coordinate with molybdate and participate in pH-dependent supramolecular assembly, providing a functional nanocomplex for local immune regulation.16

Tannic acid has been reported to modulate macrophage inflammatory signaling.20 Tannic acid and proanthocyanidins were incorporated as complementary polyphenolic components to provide radical-scavenging activity. Gelatin methacryloyl (GelMA), a photocrosslinkable derivative of the biological macromolecule gelatin, can form an injectable hydrated network that retains functional components at irregular periodontal sites.7,21 The COS-molybdate nanocomplex was incorporated as a functional nanozyme unit for immunometabolic and redox-related regulation, consistent with previous work on molybdenum-containing immunomodulatory materials.15,16 Incorporation of these components into the GelMA network may therefore integrate pH-dependent component availability, radical scavenging, catalase-like H2O2 decomposition, and mitochondria-associated immune regulation within a single macromolecular scaffold.

Here, we developed an injectable and photocurable GelMA-based hydrogel containing tannic acid-functionalized chitosan oligosaccharide-molybdate nanocomplexes and proanthocyanidins (TCM-Gel) (Scheme 1). The design combines a biological macromolecular network with pH-dependent component availability, polyphenol-mediated radical scavenging, and catalase-like H2O2 decomposition accompanied by oxygen generation. We hypothesized that TCM-Gel would attenuate the oxidative stress-mitochondrial dysfunction-pro-inflammatory macrophage cycle and promote a pro-resolving phenotype, with the associated mitochondrial changes interpreted within a broader SIRT1/PGC-1α regulatory framework, while the GelMA network would provide local retention and structural support. We therefore evaluated the molecular and physicochemical characteristics of the system, its effects on macrophage mitochondrial homeostasis and gingival fibroblast function, and its therapeutic performance in experimental periodontitis.

Scheme 1.

Two-part schematic of Gel synthesis pathway and TCM-gel periodontal repair mechanism in periodontitis. A) Gel synthesis pathway schematic. Text at top reads, Gel synthesis pathway. At left, GelMA plus Pro is shown next to an arrow labeled, UV, leading to a crosslinked polymer network, then an arrow to a hydrogel block labeled, TCM-gel. A callout to the right labeled, TCM, shows three labeled components, COS, TA and MoO subscript 4, with dashed connectors between them. Three interaction notes are printed at right: Coordination and electrostatic interactions; Hydrogen bonds and electrostatic interactions; Coordination. B) Periodontal repair mechanism schematic. Text at top reads, TCM-gel periodontal repair mechanism. Three tooth cross sections are arranged left to right with headings, Healthy periodontal, Periodontitis and Periodontal rehabilitation, connected by dashed right pointing arrows. Under the left tooth, text reads, Thread ligation method. Under the middle tooth, text reads, Alveolar bone resorption and a syringe points to the gum with the label, Periodontal injection. Under the right tooth, text reads, Microenvironment restoration. A lower strip shows a tooth and surrounding tissue at left with a label, TCM-gel and an arrow labeled, pH down, Release, leading to labeled components, GelMA, Pro, MoO subscript 4 and TCM. A line labeled, Macrophage polarization, shows M1 and M2 icons. Another line labeled, Macrophage mitochondrial enhancement, includes mitochondrion icons. A small label, ROS down, appears near the macrophage pathway. At the right side, arrows point to text, Inflammation down, Bone regeneration up and Osteogenesis up, next to a tooth cross section with bone and round particle shapes near the bone surface.

Design and proposed action of the pH-responsive injectable TCM-Gel platform. Tannic acid-functionalized chitosan-molybdate nanocomplexes and proanthocyanidins are incorporated within a gelatin methacryloyl matrix. The platform combines microenvironment-responsive component availability, radical scavenging, and catalase-like H2O2 decomposition with changes in macrophage mitochondrial homeostasis and polarization markers. These responses are associated with reduced bone resorption and increased EMCN staining in vivo.

Materials and Methods

Materials

Ammonium molybdate ((NH4)2MoO4) and TA were purchased from Macklin Biochemical Co., Ltd. (Shanghai, China). Chitosan oligosaccharide (Mw<1000 Da) was purchased from Dalian GlycoBio Co., Ltd. (Dalian, China). Gelatin methacryloyl (GelMA) and the photoinitiator lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Proanthocyanidins (Pro) were purchased from Yuanye Bio-Technology Co., Ltd. (Shanghai, China). The murine macrophage cell line RAW264.7 was obtained from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China). Human gingival fibroblasts (hGFs, CP-H240) were purchased from Procell Life Science and Technology Co., Ltd. (Wuhan, China).

Synthesis and Characterization of TCM Nanozymes

TCM nanozymes were prepared through a two-step self-assembly process. First, chitosan molybdate (CMO) nanoparticles were generated through coordination between molybdate anions and COS in water. Briefly, 6 g COS was dissolved in 100 mL deionized water. Then, 100 mL ammonium molybdate solution at 5 mg mL-1 was added. The resulting CMO nanoparticles were collected for subsequent modification. In the second step, tannic acid was introduced to functionalize the CMO surface through its abundant phenolic hydroxyl groups, thereby yielding the final TCM nanozymes. The particles were collected by centrifugation and lyophilized.

The degree-of-polymerization distribution of COS was analyzed by high-performance liquid chromatography (HPLC), and its structural proton assignments and degree of deacetylation (DD) were evaluated by 1H nuclear magnetic resonance (1H NMR) spectroscopy based on the integral of the residual N-acetyl methyl proton signal. The morphology and size of the TCM nanozymes were examined by field-emission scanning electron microscopy (FE-SEM, ULTRA 55, Zeiss, Germany) and transmission electron microscopy (TEM, JEM-F200, JEOL, Japan). Elemental composition and distribution were analyzed by energy-dispersive X-ray spectroscopy (EDS) coupled to TEM. Chemical structure and thermal behavior were evaluated by Fourier-transform infrared spectroscopy (FTIR, Nicolet iS 10, Thermo Scientific, USA) and thermogravimetric analysis (TGA, NETZSCH, Germany), respectively.

Preparation and Characterization of TCM-Gel Hydrogels

A GelMA precursor solution (10% w/v) was prepared by adding 0.005 g proanthocyanidins (Pro) to 0.5 mL photoinitiator (LAP) solution under stirring until fully dissolved. Subsequently, 0.05 g GelMA was added and dissolved to obtain a homogeneous prepolymer solution. Thereafter, 100 µL of TCM dispersion (1 mg mL−1) was added and homogenized by ultrasonication to yield the TCM-Gel precursor (final TCM content: 0.1 mg per batch). The precursor was photocrosslinked under 397 nm light irradiation for 1 min to form TCM-Gel. The microstructure of freeze-dried hydrogels was observed by SEM. Rheological behavior, including storage modulus (G′) and loss modulus (G″), was measured using a rheometer (MCR 302, Anton Paar, Austria). For the pH-dependent release assay, samples were incubated under buffer conditions of pH 5.5, 7.4, and 8.5, and cumulative COS and molybdenum release was monitored over 7 days.

The cyclic compressive behavior of the hydrogels was further evaluated through repeated loading-unloading cycles with a maximum strain of 20%, and stress-strain curves were recorded to assess resilience and fatigue resistance.

Biocompatibility and Antioxidant Capacity Assessment

First, 1 g of TCM-Gel was incubated in 10 mL of DMEM at 37 °C for 24 h. The sample was then centrifuged for 5 min, and the supernatant was collected as the hydrogel extract. The GelMA group was subjected to the same procedure. Cytocompatibility was examined by exposing RAW264.7 cells to TCM-Gel extracts for 1 or 5 days, followed by CCK-8 analysis. Radical-scavenging capacity of TA, COS, MoO42−, TCM, GelMA, and TCM-Gel was assessed using DPPH and ABTS assays, with activity calculated from the reduction in absorbance (n = 3).

CAT-like behavior was evaluated from H2O2 consumption together with time-dependent dissolved oxygen production (n = 3). Intracellular ROS was measured using 2’,7’-dichlorofluorescin diacetate (DCFH-DA, Beyotime, China), and total ROS levels were quantified by flow cytometry as mean fluorescence intensity. The activities of intracellular antioxidant enzymes, including superoxide dismutase (SOD) and CAT, were determined using commercial assay kits (Beyotime, China).

Macrophage Polarization Assays

RAW264.7 cells were challenged with LPS at 100 ng mL−1 and then incubated with TCM-Gel extracts for 24 h. Polarization status was evaluated by flow cytometric (FACS Calibur, BD Biosciences, USA) detection of CD80 and CD206. The concentrations of tumor necrosis factor-α (TNF-α) and interleukin-10 (IL-10) in the culture supernatants were measured using enzyme-linked immunosorbent assay kits (RayBiotech, USA).

Analysis of Mitochondrial Function and Molecular Mechanisms

To evaluate the effect of TCM-Gel on mitochondrial status, cells were treated with hydrogel extracts and then analyzed. Mitochondrial membrane potential (MMP) was determined with a JC-1 assay kit (Beyotime, China). Mitochondrial mass was assessed using MitoTracker Deep Red (Thermo Fisher Scientific, USA). Mitochondrial ultrastructure was observed by TEM. The transcription of SIRT1 and representative mitochondrial respiratory-chain components was analyzed by quantitative real-time polymerase chain reaction (qRT-PCR).

Global metabolic and inflammatory changes were further profiled using SWATH/DIA-based quantitative proteomics (n = 3). Proteins were extracted with lysis buffer, quantified by BCA, reduced/alkylated, and digested with trypsin at 37 °C for 2 h. After C18 desalting, peptides were separated on a Vanquish Neo UHPLC and analyzed by DIA on an Orbitrap Astral. DIA-NN (v1.9) was used with trypsin and two missed cleavages; precursor and protein identifications were filtered at 1% FDR. Differentially expressed proteins were defined as |log2FC| ≥ 1 and FDR < 0.05, followed by GO/KEGG enrichment.

Assessment of Regulatory Effects on Periodontal Tissue Cell Homeostasis

hGFs were pretreated with TCM-Gel extracts before LPS stimulation. Cell viability and membrane integrity were assessed using a Live/Dead Viability/Cytotoxicity Kit (Thermo Fisher Scientific, USA). Osteogenic differentiation was evaluated by Alizarin Red S staining for calcium deposition and by Western blot analysis of alkaline phosphatase (ALP) and runt-related transcription factor 2 (RUNX2). Ferroptosis-associated protein markers, including p53, acyl-CoA synthetase long-chain family member 4 (ACSL4, also termed FACL4), and glutathione peroxidase 4 (GPX4), were assessed by Western blot analysis.

In vivo Periodontitis Model

Male C57BL/6J mice aged 9–12 weeks were purchased from Guangzhou Ruige Biotechnology Co., Ltd. The mice were housed under specific-pathogen-free conditions in a temperature- and humidity-controlled room with a 12-h light/dark cycle and ad libitum access to standard chow and water. All animal procedures were conducted at the animal facility of Guangzhou Ruige Biotechnology Co., Ltd. The protocol complied with institutional requirements for laboratory animal care and was approved by the Institutional Animal Care and Use Committee of Ruige Biotechnology (Approval No. 20240501–001).

All procedures involving ligature placement and local administration were performed under inhalational anesthesia. Anesthesia was induced with 4% isoflurane in 100% oxygen at a flow rate of 1–3 L/min and maintained with 1.5–2.5% isoflurane delivered through a nose cone at an oxygen flow rate of 0.5–1 L/min. Adequate anesthetic depth was confirmed by the absence of a pedal withdrawal response. Before model induction, each mouse was assigned a unique identification number, and its body weight, cage location, and source were recorded. The mice were then randomly allocated to a healthy control cohort or a ligature-induced periodontitis cohort. Healthy control mice did not receive ligatures and were not included in the subsequent treatment randomization. Periodontitis was induced by placing a 5–0 sterile silk ligature around the cervix of the maxillary second molar. Six days after ligature placement, only mice in the ligature cohort were assigned, according to a prespecified random sequence, to Ligature + PBS or Ligature + TCM-Gel groups (n = 5 per group). The random sequence was generated in Microsoft Excel using the RAND() function, and the ligature-cohort mice were allocated in ascending order of the generated random numbers. For local administration, under inhalational anesthesia, the material was applied at six anatomical sites around the maxillary second molar, including the mesial buccal, distal buccal, mesial palatal, distal palatal, and mesial and distal gingival papillae. TCM-Gel was administered at 10 μL per site (60 μL per molar per treatment). Each site was exposed to 397-nm light for 10s, for a total irradiation time of 60s, to promote in situ photocrosslinking. The Ligature + PBS group received PBS at the same sites and volume and underwent the same light exposure procedure. Treatments were administered every other day under the same anesthesia regimen. The animals were monitored until full recovery after each anesthetic procedure. The silk ligatures were removed on day 12 after modeling, and the two treatment groups continued to receive their assigned local treatments until day 18. Outcome evaluation, histological assessment, micro-CT quantification, and statistical analysis were performed using coded group labels, and the analysts were blinded to treatment allocation.

On day 18, the mice were euthanized in a non-prefilled chamber by gradual-fill inhalation of 100% compressed CO2 at a displacement rate of 30% of the chamber volume per minute. CO2 flow was maintained for at least 1 min after cessation of spontaneous respiration, after which cervical dislocation was performed as a secondary physical method. Death was confirmed by the sustained absence of spontaneous respiration and heartbeat before tissue collection. For evaluation of the acute local tissue response, TCM-Gel was injected subcutaneously into the dorsal region of a separate cohort of mice (n = 3) under the same isoflurane anesthesia regimen. Five days after injection, the mice were euthanized using the CO2 procedure described above, and tissues surrounding the injection sites were collected and processed for H&E staining.

Micro-Computed Tomography (Micro-CT) Analysis

After euthanasia, maxillary samples including the molar area were collected and fixed in 10% neutral buffered formalin for 48 h. Alveolar bone morphology was then assessed by micro-computed tomography (SkyScan 1276, Bruker, Belgium). The acquired datasets were processed with the accompanying software to generate three-dimensional reconstructions and two-dimensional sectional images. Orientation and ROI definition followed the previously described method.22 Briefly, at a unified three-dimensional position, the mean distance from the cementoenamel junction to the alveolar bone crest (CEJ-ABC) at the mesial and distal sides of the maxillary second molar was measured to quantify alveolar bone loss. A consistent ROI encompassing the alveolar bone around the maxillary second molar was defined in CTAn (SkyScan), and all samples were processed using the same segmentation strategy and analytical workflow. The following morphometric parameters were calculated, namely bone volume fraction (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), and trabecular separation (Tb.Sp). To minimize bias, all micro-CT measurements were performed under blinded conditions using coded samples, and a second investigator rechecked a subset of specimens.

Histological and Immunohistochemical Analyses

The harvested maxillary specimens were decalcified with EDTA, dehydrated in a graded ethanol series, cleared in xylene, and embedded in paraffin wax. Serial sagittal sections (4 µm thickness) were prepared for histological and immunohistochemical (IHC) staining. Hematoxylin and eosin (H&E) staining was performed to assess tissue morphology and inflammatory cell infiltration. Tartrate-resistant acid phosphatase (TRAP) staining was employed to identify and semiquantitatively analyze osteoclasts. For IHC analysis, sections were stained for interleukin-6 (IL-6), macrophage markers (CD80 and CD206), an endothelial cell marker (EMCN), and a key mitochondrial regulatory protein (SIRT1). Specifically, primary antibodies against IL-6 (Servicebio, GB11117, 1:1000), CD80 (HUABIO, 1007–8, 1:1600), CD206 (Servicebio, GB113497, 1:800), EMCN (Bioss, bs-5884R, 1:200), and SIRT1 (Servicebio, GB11171, 1:1000) were used. All images were acquired using a digital pathology slide scanner (PANNORAMIC MIDI II, 3DHISTECH). Semiquantitative analysis was performed using ImageJ software (version 1.54p, NIH, USA). All histological and immunohistochemical quantifications were performed in a blinded manner.

Statistical Analysis

All quantitative data are presented as mean ± standard deviation (SD). Statistical analyses were based on independent biological replicates or independent animals; when technical replicates were performed, their values were averaged within the same independent experimental unit before analysis. Unless otherwise indicated, n denotes the number of independent biological samples or animals. In vitro experiments used n = 3 independent biological replicates, the periodontitis-treatment experiment used n = 5 mice per group, and the local tissue-response experiment used n = 3 mice. Sample sizes were selected with reference to comparable animal studies, preliminary model and treatment experiments, and the 3Rs principle. The Shapiro–Wilk test was used to assess normality before statistical analysis. Given the small sample sizes, normality-test results and inferential statistics were interpreted cautiously. An unpaired Student’s t-test was used for comparisons between two groups, and one-way analysis of variance followed by Tukey’s post hoc test was used for multiple-group comparisons. A value of P < 0.05 was considered statistically significant. Statistical analysis was conducted using SPSS software (version 20.0, IBM Corp., Armonk, NY, USA). Graphs were prepared using GraphPad Prism (version 9.0, GraphPad Software, San Diego, CA, USA).

Results

Preparation and Physicochemical Characterization of TCM-Gel Hydrogels

To develop a microenvironment-adaptive biomaterial platform for redox-oxygenation-assisted immunometabolic modulation, a multifunctional hydrogel based on tannic acid-modified chitosan-molybdate nanocomplexes (TCM-Gel) was designed and synthesized. The synthetic pathway is illustrated in Figures 1A and 2A. First, spherical chitosan molybdate (CMO) nanoparticles were prepared via coordinative self-assembly of molybdate anions and COS. These particles were subsequently surface-modified with tannic acid (TA) to obtain the final TCM nanocomplex. The TCM nanocomplex was then uniformly dispersed into a GelMA precursor solution containing proanthocyanidins (Pro) and photocrosslinked under 397 nm light irradiation to form TCM-Gel.

Figure 1.

A multi-part scientific infographic on TCM nanozymes with synthesis, microscopy and physical characterization plots. A) Reaction scheme labeled Chitin above a bracketed COS repeat unit labeled n equals 2 dash 10. At left is (NH subscript 4 end subscript) subscript 2 end subscript MoO subscript 4 end subscript plus COS plus TA, followed by the text, Self assembly, leading to TCM shown as three circular particles. B) Scanning electron micrograph with a scale bar labeled 1 micrometers and an inset labeled 100 nm. Elemental mapping images labeled C, N, O and Mo, each with a scale bar labeled 1 micrometers. An energy dispersive spectrum plot with an embedded table labeled Element, Weight(percent) and Atom(percent). Table entries: C 71.31 and 79.71; N 2.70 and 2.59; O 20.10 and 16.87; Mo 5.89 and 0.82. C) Transmission electron micrograph with a scale bar labeled 20 nm and an inset diffraction pattern. D) Histogram with y axis label Frequency (percent) and x axis label Size (nm). X axis tick labels run from 20 to 110. Bars span roughly 25 to 105 nm, with the tallest bar around 40 to 50 nm at about 35 percent. E) Spectra plot with y axis label Transmittance (percent) and x axis label Wavenumber (cm superscript minus 1 end superscript). Three labeled traces: TA, TCM and COS. F) Thermogravimetric plot with x axis label Temperature (degree C). Left y axis label TG (percent) and right y axis label DTG (percent per degree C). Two labeled curves, TG (percent) and DTG (percent per minute), shown across 60 to 500 degree C. G) Line graph with y axis label Accumulated release of COS (micrograms per mL) and x axis tick labels 1d, 3d and 7d. Three series labeled pH equals 8.5, pH equals 7.4 and pH equals 5.5. Approximate values: at 1d about 40, 35 and 25; at 3d about 120, 90 and 60; at 7d about 190, 160 and 90. H) Line graph with y axis label Accumulated release of Mo (micrograms per mL) and x axis tick labels 1d, 3d and 7d. Three series labeled pH equals 8.5, pH equals 7.4 and pH equals 5.5. Approximate values: at 1d about 55, 50 and 15; at 3d about 120, 115 and 40; at 7d about 175, 170 and 65.

Preparation and physicochemical characterization of TCM nanozymes. (A) Synthetic pathway. (B) SEM image and EDS elemental mapping. (C) TEM image. (D) Particle-size distribution, showing an average diameter of 70–80 nm. (E) FTIR spectra of chitosan oligosaccharide (COS), tannic acid (TA), and TCM nanozymes, showing spectral shifts consistent with coordination and intermolecular interactions. (F) TGA mass-loss profile. (G and H) pH-responsive cumulative release profiles of COS and molybdenum over 7 days.

Figure 2.

A multi-part scientific infographic on TCM-Gel preparation and tests including SEM, graphs, assays and kinetics. A) Reaction schematic with labels, GelMA, then Grafting with Procyanidine to form GelMA or GelMA/Pro, then addition of TCM and UV to form TCM-Gel, ending with a disk-shaped hydrogel cartoon. B) Three scanning electron micrographs labeled, GelMA, GelMA/Pro and TCM-Gel, each showing a porous, sheet-like internal structure; scale bars read 20 micrometer, 10 micrometer and 20 micrometer. C) A line graph of Modulus (Pa) versus Temperature (degrees C) with two curves labeled, G prime (Pa) and G double prime (Pa); the y-axis is logarithmic with ticks at 1 times 10 to the power of 2, 1 times 10 to the power of 3, 1 times 10 to the power of 4 and 1 times 10 to the power of 5 and the x-axis shows 0 to 40. The G prime curve decreases from about 1 times 10 to the power of 5 near 0 to 10 degrees C to a minimum near 1 times 10 to the power of 2 around the mid 30s degrees C, then rises toward about 1 times 10 to the power of 4 by about 40 degrees C. The G double prime curve stays around 1 times 10 to the power of 3 at low temperature, dips toward about 1 times 10 to the power of 2 in the mid 30s degrees C, then rises toward about 1 times 10 to the power of 3 to 1 times 10 to the power of 4 near 40 degrees C. An inset photo shows a hydrogel sample held between two gloved fingers. D) Three stress strain plots labeled, GelMA, GelMA/Pro and TCM or Gel. Each plot has x-axis Strain (percent) from 0 to 25 and y-axis Stress (MPa). The GelMA plot shows multiple loading cycles rising to about 6 times 10 to the power of minus 3 MPa by about 20 to 22 percent strain. The GelMA/Pro plot shows cycles rising to about 8 times 10 to the power of minus 3 MPa by about 20 to 22 percent strain. The TCM or Gel plot shows cycles rising to about 6 times 10 to the power of minus 3 MPa by about 20 to 22 percent strain. E) A row of test tubes labeled, DPPH, TA, COS, Mo, CMO, TCM, Gel and TCM-Gel. F) Left, a multi-line absorbance spectrum with x-axis Wavelength (nm) from 400 to 600 and y-axis Absorbance from 0 to 2.5, with curves labeled DPPH, TA, COS, Mo, CMO, TCM, Gel and TCM-Gel; the curves show a main peak around 520 nm with different heights. Right, a bar chart with y-axis DPPH scavenging rate (percent) from 0 to 150 and categories TA, COS, Mo, CMO, TCM, Gel and TCM-Gel; approximate bar heights are TA about 90, COS about 40, Mo about 50, CMO about 120, TCM about 130, Gel about 30 and TCM-Gel about 120, with triple asterisk markers above several comparisons. G) A row of test tubes labeled, ABTS, TA, COS, Mo, CMO, TCM, Gel and TCM-Gel. H) Left, a multi-line absorbance spectrum with x-axis Wavelength (nm) from 500 to 1000 and y-axis Absorbance from 0 to 2.5, with curves labeled ABTS, TA, COS, Mo, CMO, TCM, Gel and TCM-Gel; the curves form a broad peak between about 650 and 850 nm with different heights. Right, a bar chart with y-axis ABTS scavenging rate (percent) from 0 to 120 and categories TA, COS, Mo, CMO, TCM, Gel and TCM-Gel; approximate bar heights are TA about 80, COS about 30, Mo about 10, CMO about 15, TCM about 90, Gel about 20 and TCM-Gel about 60, with triple asterisk markers above several comparisons. I) Four photos of a beaker labeled t equals 0 s, t equals 1 s, t equals 3 s and t equals 3 h, showing suspended particles and bubbles; arrows point to floating particles and bubble regions. J) A line graph of Dissolved O subscript 2 (mg per L) versus Time (min). The x-axis shows 0, 1, 2, 3, 5, 10 and 15. Three series are labeled PBS, H subscript 2 O subscript 2 and TCM plus H subscript 2 O subscript 2. PBS stays near 9 across all times. H subscript 2 O subscript 2 rises from about 11 at 0 to about 12 at 15. TCM plus H subscript 2 O subscript 2 rises from about 11 at 0 to about 17 at 15, with error bars on points.

(A) Schematic of the TCM-Gel hydrogel preparation via photocrosslinking of a GelMA precursor solution containing TCM nanozymes and proanthocyanidins. (B) SEM image of the porous architecture of lyophilized TCM-Gel. (C) Macroscopic appearance and rheological properties of the TCM-Gel. (D) Cyclic compression performance test of the TCM-Gel. (E) DPPH scavenging test and (F) DPPH scavenging activity of TCM-Gel (n = 3); (G) ABTS scavenging test and (H) ABTS scavenging activity of TCM-Gel (n = 3); (I and J) CAT-mimetic kinetics showing time-dependent H2O2 degradation. Red arrows indicate the floating movement of particles and the oxygen bubbles (n = 3). Data are presented as mean ± SD. ***p < 0.001.

Before constructing the TCM nanozyme, the commercial COS precursor was further characterized to provide relevant structural information. HPLC analysis showed that the COS sample was mainly composed of low-molecular-weight oligomers with degrees of polymerization of 2–6, corresponding to a molecular-weight distribution below 1000 Da (Figure S1). In the 1H NMR spectrum (Figure S2; Table S1), the glycan-ring methine/methylene proton signals at δ 3.2–4.0 ppm and the anomeric proton signals at δ 4.5–4.6 ppm were clearly assigned, consistent with the reported chitosan oligosaccharide backbone. No obvious methyl proton signal of N-acetyl groups (-COCH3) was detected near δ 2.0 ppm. Integral analysis indicated a degree of deacetylation above 99% (DD > 99%), confirming that the COS used in this study was highly deacetylated. The clean spectral baseline and absence of prominent additional peaks suggested no detectable structural impurity signals.

We next characterized the TCM nanozyme. SEM and TEM observations showed uniformly spherical particles with an average diameter of 70–80 nm (Figure 1B–D). EDS mapping demonstrated homogeneous distributions of C, N, O, and Mo, and the mass fraction of Mo was approximately 5.89% (Figure 1B). TA exhibited a broad phenolic hydroxyl absorption band at 3200–3600 cm−1, benzene-ring skeletal vibrations at 1600 and 1510 cm−1, and C-O stretching vibrations at 1200–1000 cm−1. COS showed a broad band at 3200–3500 cm−1 corresponding to overlapping amino and hydroxyl stretching vibrations, an amide I band at 1650 cm−1, an amino bending vibration at 1590 cm−1, and characteristic sugar-ring fingerprint peaks at 1150–1030 cm−1. In the TCM spectrum, broadening at 3200–3600 cm−1 was consistent with hydrogen bonding between TA and COS, shifts at 1650–1550 cm−1 were consistent with amino-group participation in coordination interactions, and Mo-O vibration bands supported molybdate coordination with COS amino groups (Figure 1E). Together, these spectral changes were consistent with molybdate-COS coordination and intermolecular interactions among molybdate, COS, and tannic acid that contribute to TCM supramolecular assembly.

Thermogravimetric analysis of TCM showed limited mass loss below approximately 250 °C, with the initial loss at 25–100 °C attributed mainly to water evaporation. The principal decomposition occurred at 250–350 °C. The derivative thermogravimetry curve showed a bimodal feature at 250–300 °C, which may reflect sequential decomposition of the TA-rich outer region and the COS-containing core (Figure 1F).

Because the pH of gingival crevicular fluid and periodontal pockets can vary with local conditions, we examined cargo release at pH 5.5, 7.4, and 8.5 as comparative experimental conditions. Both COS and released molybdenum showed greater cumulative release at pH 8.5 than at neutral or acidic pH, indicating pH-dependent component availability under the tested conditions (Figure 1G and H). This profile indicates that the system responds to environmental pH under the tested conditions, whereas the in vivo relevance of a particular periodontal pH range requires further evaluation.

The lyophilized TCM-Gel displayed an interconnected three-dimensional porous network resembling extracellular matrix, which may support cell infiltration and nutrient diffusion (Figure 2A and B). Rheological testing showed that the storage modulus (G′) remained higher than the loss modulus (G″) across 5–45°C, indicating a predominantly elastic and stable gel state with no obvious sol-gel transition in this range (Figure 2C). Moreover, cyclic compression loading-unloading tests showed stable stress-strain profiles over repeated cycles up to 20% strain, suggesting favorable elasticity and fatigue resistance for oral local application (Figure 2D). Given the association between periodontitis and oxidative stress, we assessed the antioxidant and enzyme-mimetic properties of the system. In DPPH and ABTS radical-scavenging assays, TCM-Gel showed greater free-radical scavenging capacity than the GelMA control (Figure 2E–H). The TCM nanozymes also catalyzed H2O2 decomposition accompanied by oxygen evolution, and dissolved oxygen increased over time in the TCM + H2O2 group compared with PBS or H2O2 alone, supporting catalase-like activity (Figure 2I and J).

Effects of TCM-Gel on Macrophage Phenotype and Mitochondrial Indices

We first examined the effects of TCM-Gel on macrophage polarization and mitochondrial function in vitro. CCK-8 results showed that TCM-Gel did not reduce RAW264.7 cell proliferation during 5 days of coculture (P < 0.01), supporting cytocompatibility under the tested conditions (Figure 3A).

Figure 3.

A multi-panel figure with 9 bar charts and microscopy images comparing Control, IL-4, GSH and TCM-Gel. A) A bar chart with y-axis label, OD value (450 nanometer) and x-axis categories, 1d and 5d. Two bars per category labeled, Control and TCM-Gel. At 1d, Control is about 1.6 and TCM-Gel is about 2.3, with a double asterisk above. At 5d, Control is about 3.4 and TCM-Gel is about 3.6, with a double asterisk above. B) A bar chart with y-axis label, Relative CD206 or CD80 and x-axis categories, Control, IL-4, GSH and TCM-Gel. Bar heights are about 1.0 for Control, about 1.3 for IL-4, about 1.0 for GSH and about 1.8 for TCM-Gel. Three separate triple asterisk brackets compare IL-4 to TCM-Gel, GSH to TCM-Gel and Control to TCM-Gel. C) A bar chart with y-axis label, IL-10 (pg per mL) and x-axis categories, 1d and 3d. Two bars per category labeled, Control and TCM-Gel. At 1d, Control is about 120 and TCM-Gel is about 230, with a triple asterisk above. At 3d, Control is about 130 and TCM-Gel is about 320, with a triple asterisk above. D) A bar chart with y-axis label, TNF-alpha (pg per mL) and x-axis categories, 1d and 3d. Two bars per category labeled, Control and TCM-Gel. At 1d, Control is about 120 and TCM-Gel is about 70, with a triple asterisk above. At 3d, Control is about 115 and TCM-Gel is about 75, with a triple asterisk above. E) A 3 by 4 grid of fluorescence micrographs with column headers, Control, IL-4, GSH and TCM-Gel and row labels, J-monomer, J-aggregate and Merge. Each micrograph includes a 100 micrometer scale bar. The J-monomer row shows punctate cellular fluorescence across all four conditions. The J-aggregate row shows clustered cellular fluorescence across all four conditions. The Merge row shows combined signals with varying proportions of the two signals across the four conditions. F) A bar chart with y-axis label, JC-1 fluorescence left parenthesis red over green right parenthesis and x-axis categories, Control, IL-4, GSH and TCM-Gel. Bar heights are about 4 for Control, about 12 for IL-4, about 5 for GSH and about 7 for TCM-Gel. Triple asterisk brackets are shown for IL-4 versus GSH, IL-4 versus TCM-Gel and GSH versus TCM-Gel. G) A bar chart with y-axis label, DCFH-DA ratio (percent) and x-axis categories, H2O2, IL-4, GSH and TCM-Gel. Bar heights are about 100 for H2O2, about 55 for IL-4, about 70 for GSH and about 10 for TCM-Gel. Triple asterisk brackets compare H2O2 to IL-4, H2O2 to GSH and H2O2 to TCM-Gel. H) A bar chart with y-axis label, SOD activity (units) and x-axis categories, Control, IL-4, GSH and TCM-Gel. Bar heights are about 0.3 for Control, about 0.45 for IL-4, about 0.7 for GSH and about 0.45 for TCM-Gel. A triple asterisk bracket spans Control to GSH and another triple asterisk bracket spans GSH to TCM-Gel. I) A bar chart with y-axis label, CAT activity left parenthesis micromole per 10 to the power of 6 cell per minute right parenthesis and x-axis categories, Control, IL-4, GSH and TCM-Gel. Bar heights are about 2.5 for Control, about 4.8 for IL-4, about 3.0 for GSH and about 5.0 for TCM-Gel. A triple asterisk bracket spans IL-4 to TCM-Gel and a double asterisk bracket spans GSH to TCM-Gel. J) Four fluorescence micrographs with column headers, Control, IL-4, GSH and TCM-Gel, each with a 100 micrometer scale bar, followed by a bar chart. The micrographs show punctate mitochondrial fluorescence within cells across all four conditions. The bar chart y-axis label reads, Fluorescence intensity of mitochondrial mass (percent) and the x-axis categories are Control, IL-4, GSH and TCM-Gel. Bar heights are about 10 for Control, about 55 for IL-4, about 35 for GSH and about 65 for TCM-Gel. Triple asterisk brackets compare IL-4 to TCM-Gel, GSH to TCM-Gel and Control to TCM-Gel.

Effects of TCM-Gel on macrophage polarization markers and mitochondrial indices in vitro. (A) Assessment of TCM-Gel hydrogel cytocompatibility via CCK-8 assay. (B) The CD206/CD80 ratio was quantified using flow cytometry. (C and D) Quantification by ELISA of the anti-inflammatory cytokine IL-10 (C) and the pro-inflammatory cytokine TNF-α (D) secreted by macrophages. (E) Fluorescence microscopy images of JC-1 staining to assess the mitochondrial membrane potential (MMP) in macrophages. Red fluorescence (J-aggregates) indicates high MMP, while green fluorescence (J-monomers) indicates low MMP. (F) Quantification of the red/green fluorescence intensity ratio. (G) Intracellular reactive oxygen species (ROS) levels detected by the DCFH-DA probe. (H and I) Activity assays of the endogenous antioxidant enzymes superoxide dismutase (SOD) (H) and catalase (CAT) (I). (J) Assessment of mitochondrial mass by MitoTracker Deep Red staining. Data are presented as mean ± SD. **p < 0.01, ***p < 0.001.

Macrophage responses to TCM-Gel were then analyzed by flow cytometry and cytokine assays. The CD206/CD80 ratio was significantly higher in the TCM-Gel group (~1.85) than in the control, IL-4, and GSH groups (P < 0.001; Figure 3B). TCM-Gel-treated macrophages secreted more IL-10 at days 1 and 3 (~240 and ~320 pg/mL vs ~120 and ~125 pg/mL in control; P < 0.001) while maintaining lower TNF-α levels (~70 and ~75 pg/mL vs ~125 and ~120 pg/mL; P < 0.001) (Figure 3C and D). These findings indicate a shift in macrophage markers and cytokine secretion toward a pro-resolving profile. Because previous work showed marked radical-scavenging activity of CMO,16 we further examined whether this response was accompanied by changes in macrophage mitochondrial function, including ROS levels, mitochondrial membrane potential, antioxidant enzyme activity, and transcription of mitochondrial-function-related genes.

Because mitochondrial redox homeostasis is closely linked to macrophage phenotype and inflammatory regulation,23 we next examined mitochondrial function after 72 h of coculture. MMP was measured using JC-1, whose accumulation in mitochondria depends on membrane potential. An increased red/green fluorescence ratio indicates a stronger proton gradient across the inner mitochondrial membrane and thus better mitochondrial function.23 As shown in Figure 3E and F, TCM-Gel significantly increased the JC-1 red/green ratio (~6.7) compared with the control (~3.2) and GSH (~4.2) groups (P < 0.001), indicating preservation of MMP. DCFH-DA fluorescence was lower in the TCM-Gel group (~8%) than in the H2O2 positive control (~95%) and GSH group (~72%) (P < 0.001; Figure 3G), indicating reduced intracellular ROS. TCM-Gel also increased CAT activity (~5.1 vs ~2.3 in control; P < 0.001) and MitoTracker fluorescence intensity (~63 vs ~8 in control; P < 0.001), and showed a trend toward higher SOD activity (~0.44 vs ~0.32 in control) (Figure 3H–J).

IL-4 can reprogram macrophages through STAT6 activation and upregulate antioxidant enzymes such as SOD and CAT while promoting mitochondrial biogenesis.24 By contrast, glutathione acts as a direct intracellular antioxidant and a cofactor for glutathione peroxidase during peroxide detoxification.25 Under the tested conditions, TCM-Gel produced greater increases in the CD206/CD80 ratio, mitochondrial membrane potential, SOD/CAT activities, and mitochondrial fluorescence intensity than the IL-4 and GSH comparison groups (Figure 3).

TCM-Gel is Associated with Increased SIRT1 and Respiratory-Chain Transcripts

To further examine the mitochondrial changes associated with TCM-Gel treatment, we considered the SIRT1/PGC-1α regulatory framework, a pathway implicated in mitochondrial biogenesis (Figure 4A). Peroxisome proliferator-activated receptor-gamma coactivator-1 α (PGC-1α) is a transcriptional coactivator that promotes mitochondrial oxidative metabolism, and its upregulation enhances mitochondrial resistance to oxidative stress. By improving mitochondrial function, PGC-1α also supports the acquisition of an anti-inflammatory macrophage phenotype. SIRT1 is an important upstream regulator of this biogenic program. The present study directly assessed SIRT1 and selected mitochondrial indices; PGC-1α was not directly measured.

Figure 4.

A multi-part figure with a pathway schematic, two micrographs and 5 bar charts comparing Control and TCM-Gel. A) Mitochondrial biogenesis schematic. SIRT1 connects to Ac, which connects to PGC-1a. AMPK connects to P, which connects to PGC-1a. PGC-1a points down to another PGC-1a above a DNA strand with a small label, TF and the text, NRF1 or NFE2/2. This points down to PGC-1a and NRF1/2 above another DNA strand, then to TFAM, then to TFAM above mtDNA. mtDNA branches to mtDNA transcription and mtDNA replication, then to SDHB, UQCRC2 and ATP5A. B) Two TEM micrographs labeled Control and TCM-Gel with multiple arrow markers pointing to mitochondria. A scale bar reads 2 micrometer. A bar chart titled by the y-axis label, Mitochondria counts left parenthesis Cell superscript minus 1 right parenthesis, with y-axis ticks at 0, 10, 20, 30. The x-axis categories are Control and TCM-Gel. The Control bar is about 8. The TCM-Gel bar is about 20. A double asterisk is shown above the comparison. C) Bar chart with y-axis label, Relative expression (SIRT1), with y-axis ticks at 0, 2, 4, 6, 8. The x-axis categories are Control and TCM-Gel. The Control bar is about 1. The TCM-Gel bar is about 5. A triple asterisk is shown above the comparison. D) Bar chart with y-axis label, Relative expression (SDHB), with y-axis ticks at 0, 1, 2, 3, 4. The x-axis categories are Control and TCM-Gel. The Control bar is about 1. The TCM-Gel bar is about 2.7. A triple asterisk is shown above the comparison. E) Bar chart with y-axis label, Relative expression (UQCRC2), with y-axis ticks at 0, 1, 2, 3, 4. The x-axis categories are Control and TCM-Gel. The Control bar is about 1. The TCM-Gel bar is about 2.9. A triple asterisk is shown above the comparison. F) Bar chart with y-axis label, Relative expression (ATP5A), with y-axis ticks at 0, 2, 4, 6, 8, 10. The x-axis categories are Control and TCM-Gel. The Control bar is about 1. The TCM-Gel bar is about 7. A triple asterisk is shown above the comparison.

TCM-Gel is associated with increased SIRT1 and respiratory-chain transcripts in macrophages. (A) Schematic diagram of the SIRT1/PGC-1α regulatory program in mitochondrial biogenesis. (B) Representative TEM images of macrophages and quantification of mitochondria per cell (yellow arrow). (C–F) qRT-PCR analysis of relative mRNA expression of (C) SIRT1 and the electron transport chain subunits (D) SDHB (Complex II), (E) UQCRC2 (Complex III), and (F) ATP5A (Complex V). Data are presented as mean ± SD. **p < 0.01, ***p < 0.001.

The mitochondrial respiratory chain comprises five enzyme complexes located in the inner mitochondrial membrane. Complexes I, II, III, and IV mediate electron transfer, whereas complex V uses the resulting proton gradient to phosphorylate ADP and generate ATP.26 Through this electron transport process, oxidation of reducing equivalents is coupled to ATP synthesis, which sustains essential cellular functions. ND4, SDHA, COX-4, and ATP5A are representative subunits of complexes I, II, IV, and V, respectively.27 TEM showed that TCM-Gel-treated macrophages contained more mitochondria (~20 vs ~8 per cell; P < 0.01; Figure 4B) with clearer cristae and more intact morphology. qRT-PCR showed increased SIRT1 mRNA expression in the TCM-Gel group (~5.2-fold vs control; P < 0.001; Figure 4C). Transcripts encoding ETC subunits SDHB (Complex II), UQCRC2 (Complex III), and ATP5A (Complex V) were also increased (~2.7-, ~2.9-, and ~7.2-fold vs control, respectively; all P < 0.001; Figure 4D–F), indicating increased transcription of representative respiratory-chain components.

Most respiratory proteins, together with many other products needed for mitochondrial function, are encoded by nuclear genes.28 Our differential expression results suggest that mitochondrial genes respond to the intervention with different sensitivities. Mitochondrial biogenesis is complex and cannot be explained by a single mechanism across all assays.27,29 Transcriptional coactivators such as PGC-1α regulate genes involved in the respiratory chain and mitochondrial transcription and replication.28 Accordingly, we used the SIRT1/PGC-1α regulatory program as a framework for interpretation and treated the expression of respiratory-chain genes as supporting evidence. Overall, TCM-Gel treatment was associated with increased SIRT1 and respiratory-chain transcripts together with improved mitochondrial abundance and functional indices.

Proteomic Analysis Identifies Mitochondrial and Inflammatory Pathway Changes

SWATH/DIA quantitative proteomics was used to compare protein-expression profiles between control and TCM-Gel-treated macrophages. Principal component analysis showed clear separation between the TCM-Gel and control groups, which indicated distinct and consistent proteomic profiles after treatment (Figure 5A). Volcano plot analysis identified a total of 389 differentially expressed proteins, with 147 proteins being upregulated and 242 downregulated (Figure 5B). A hierarchical clustering heatmap further illustrated the unique protein expression patterns between these two sample groups (Figure 5C).

Figure 5.

A multi-part proteomics infographic with PCA, volcano plot, heatmap, GO and KEGG enrichment and GSEA plots. A) Scatter plot titled Groups with x-axis label, PCA1 (41.1 percent) and y-axis label, PCA2 (24.2 percent). Legend text reads, Groups, Control and TCM-Gel. Two point clusters are enclosed by ellipses. B) Volcano scatter plot with x-axis label, Log2FC and y-axis label, minus log10(Pvalue). Legend text reads, up (147), Not sig (445) and Down (242). Dotted threshold lines are drawn on both axes. C) Hierarchical clustering heatmap with bottom labels, Control and TCM-Gel, each with sample labels 1, 2 and 3. A vertical scale bar shows minus 1, 0 and 1. A dendrogram is shown at the right side of the heatmap. D) Dot plot titled GO_BP with x-axis label, Fold Enrichment. Y-axis categories read: metabolic process; organic substance metabolic; primary metabolic; cellular metabolic; nitrogen compound metabolic; macromolecule metabolic; small molecule metabolic; regulation of hydrolase activity. Text above the plot includes, Mapping, with 50, 100, 150, 200, 250 and minus log10(Pvalue), with 10, 9, 8, 7, 6, 5. E) Horizontal bar chart titled KEGG with x-axis label, minus log10(Pvalue). Pathway labels read: Nicotinate and nicotinamide metabolism; Chemokine signaling pathway; Coronavirus disease COVID-19; Yersinia infection; Base excision repair; Salmonella infection; Neutrophil extracellular trap formation; RNA degradation; Basal transcription factors; Spliceosome; TGF-beta signaling pathway; Regulation of actin cytoskeleton; Amoebiasis; Protein digestion and absorption; Steroid biosynthesis; Focal adhesion; Mitophagy; Proteoglycans in cancer; ECM-receptor interaction; Complement and coagulation cascades. Key text reads, UP and Down. F) Dot plot titled GO_CC with x-axis label, Fold Enrichment. Y-axis categories read: intracellular anatomical structure; organelle; intracellular organelle; cytoplasm; membrane-bounded organelle; intracellular membrane-bounded organelle; cytosol; protein-containing complex; organelle lumen; membrane-enclosed lumen; intracellular organelle lumen. Text above the plot includes, Mapping, with 100, 200, 300 and minus log10(Pvalue), with 10, 8, 6. G) Dot plot titled GO_MF with x-axis label, Fold Enrichment. Y-axis categories read: molecular function regulator activity; protein-containing complex binding; enzyme regulator activity; RNA binding; enzyme inhibitor activity; peptidase regulator activity; endopeptidase regulator activity; peptidase inhibitor activity; endopeptidase inhibitor activity; protease binding. Text above the plot includes, Mapping, with 25, 50, 75 and minus log10(Pvalue), with 7, 6, 5, 4, 3. H) Four GSEA-style line plots with x-axis label, Rank in Ordered Dataset and y-axis label, Running Enrichment Score. Each plot includes barcode ticks and a ranked list metric scale labeled, Rank List Metric, Signal2Noise and the label, TCM-Gel. Titles are: Mitochondrial gene expression; Mitochondrial matrix; Regulation of inflammatory response; Inorganic ion in transmembrane transport.

Quantitative proteomics identifies mitochondrial- and inflammation-related pathway changes in TCM-Gel-treated macrophages. (A) Principal component analysis showing distinct clustering of control and TCM-Gel groups. (B) Volcano plot of differentially expressed proteins. A total of 147 significantly upregulated (red dots) and 242 significantly downregulated (blue dots) proteins were identified in the TCM-Gel group compared to the control. (C) Hierarchical clustering heatmap visually representing the unique protein expression profiles between the two sample groups. (D–G) GO functional enrichment and KEGG pathway analyses of differentially expressed proteins, revealing significant enrichment in (D) metabolism-related biological processes (BP), (E) inflammation and ECM-receptor interaction-related KEGG pathways, (F) organelle-related cellular components (CC), including mitochondria, and (G) binding and enzyme regulator-related molecular functions (MF). (H) Gene set enrichment analysis showing positive enrichment of mitochondrial gene expression and mitochondrial matrix signatures together with negative enrichment of inflammatory-response regulation.

Abbreviation: NES, normalized enrichment score.

GO analysis showed enrichment of metabolism-related biological processes and organelle-related cellular components, consistent with the observed mitochondrial phenotype (Figure 5D, F). GO molecular function analysis further showed enrichment of binding- and enzyme regulator-related functions (Figure 5G). KEGG analysis highlighted pathways related to inflammation and immune regulation, including complement and coagulation cascades and ECM-receptor interaction (Figure 5E). GSEA showed positive enrichment of protein sets associated with mitochondrial gene expression and the mitochondrial matrix and negative enrichment of sets related to regulation of inflammatory responses (Figure 5H). These proteomic changes were consistent with mitochondria-associated remodeling and reduced inflammatory signaling in TCM-Gel-treated macrophages.

TCM-Gel Protects Gingival Fibroblasts from Inflammatory Injury and Promotes Their Osteogenic Differentiation

We next investigated the direct effects of TCM-Gel on hGFs, another relevant cell type in periodontal tissue. In an LPS-induced inflammatory environment, Live/Dead staining showed that TCM-Gel pretreatment reduced the proportion of membrane-compromised cells and increased cell viability (Figure 6A, D). TCM-Gel also reduced LPS-induced intracellular ROS toward basal levels (~145 vs ~175 in LPS; P < 0.01; Figure 6B, E). In hGFs, TCM-Gel promoted mineralization and osteogenic differentiation, with greater Alizarin Red S staining and calcium deposition (~17 vs ~1.0 in control and ~0.5 in LPS; P < 0.001 vs control; Figure 6C, G), higher ALP activity (~1.5 vs ~0.65 in LPS and ~1.0 in control; P < 0.001; Figure 6F), and increased ALP and RUNX2 expression (~1.25- and ~1.5-fold vs control, respectively; P < 0.001; Figure 6I and J).

Figure 6.

A) to L) Composite microscopy, bar charts and western blots for Control, LPS and LPS plus TCM-Gel. A) Three microscopy images labeled Control, LPS and LPS plus TCM-Gel. Left-side label reads Live Dead staining. A scale bar reads 50 micrometer. B) Three microscopy images labeled Control, LPS and LPS plus TCM-Gel. Left-side label reads ROS. A scale bar reads 50 micrometer. C) Three microscopy images labeled Control, LPS and LPS plus TCM-Gel. Left-side label reads Alizarin red. A scale bar reads 50 micrometer. D) A bar chart with y-axis label, OD value at 450nm, with tick labels 0.0, 0.5, 1.0, 1.5 and 2.0. The x-axis categories are Control, LPS and LPS plus TCM-Gel. The Control bar is higher than LPS and LPS plus TCM-Gel is highest. Significance markers appear above brackets as three asterisks. E) A bar chart with y-axis label, Fluorescence intensity (ROS), with tick labels 0, 50, 100, 150, 200 and 250. The x-axis categories are Control, LPS and LPS plus TCM-Gel. The LPS bar is highest and LPS plus TCM-Gel is lower than LPS. Significance markers appear above brackets as three asterisks and two asterisks. F) A bar chart with y-axis label, Relative ALP activity, with tick labels 0.0, 0.5, 1.0, 1.5 and 2.0. The x-axis categories are Control, LPS and LPS plus TCM-Gel. The LPS bar is lower than Control and LPS plus TCM-Gel is highest. Significance markers appear above brackets as three asterisks. G) A bar chart with y-axis label, Relative calcium deposition, with tick labels 0, 5, 10, 15, 20 and 25. The x-axis categories are Control, LPS and LPS plus TCM-Gel. The LPS plus TCM-Gel bar is highest, while Control and LPS are near the baseline. Significance markers appear above brackets as three asterisks. H) Western blot bands labeled p53 and GAPDH, with lane labels Control, LPS and LPS plus TCM-Gel. Below is a bar chart with y-axis label, Relative p53 expression (fold Change), with tick labels 0.0, 0.5, 1.0, 1.5 and 2.0. The LPS bar is higher than Control and LPS plus TCM-Gel is lower than LPS. Significance markers appear above brackets as three asterisks. I) Western blot bands labeled ALP and GAPDH, with lane labels Control, LPS and LPS plus TCM-Gel. Below is a bar chart with y-axis label, Relative ALP expression (fold Change), with tick labels 0.0, 0.5, 1.0, 1.5 and 2.0. The LPS bar is lower than Control and LPS plus TCM-Gel is higher than both. Significance markers appear above brackets as three asterisks. J) Western blot bands labeled RUNX2 and GAPDH, with lane labels Control, LPS and LPS plus TCM-Gel. Below is a bar chart with y-axis label, Relative RUNX2 expression (fold Change), with tick labels 0.0, 0.5, 1.0, 1.5 and 2.0. The LPS bar is lower than Control and LPS plus TCM-Gel is highest. Significance markers appear above brackets as three asterisks. K) Western blot bands labeled FACL4 and GAPDH, with lane labels Control, LPS and LPS plus TCM-Gel. Below is a bar chart with y-axis label, Relative FACL expression (fold Change), with tick labels 0.0, 0.5, 1.0, 1.5 and 2.0. The LPS bar is higher than Control and LPS plus TCM-Gel is lower than LPS. Significance markers appear above brackets as two asterisks and three asterisks. L) Western blot bands labeled GPX4 and GAPDH, with lane labels Control, LPS and LPS plus TCM-Gel. Below is a bar chart with y-axis label, Relative GPX4 expression (fold Change), with tick labels 0.0, 0.5, 1.0, 1.5 and 2.0. The LPS bar is lower than Control and LPS plus TCM-Gel is higher than both. Significance markers appear above brackets as three asterisks.

TCM-Gel protects gingival fibroblasts under inflammatory conditions, attenuates ferroptosis-associated marker changes, and increases osteogenic markers. (A, D) Live/Dead staining and quantification of cell viability in LPS-treated hGFs with or without TCM-Gel. (B, E) Intracellular ROS and fluorescence quantification. (C, G) Alizarin Red S staining and quantification of calcium deposition after 21 days. Scale bar = 50 µm. (F) ALP activity. (H–L) Western blot analysis and quantification of p53 (H), ALP (I), RUNX2 (J), ACSL4/FACL4 (K), and GPX4 (L). GAPDH served as the loading control. Data are presented as mean ± SD. **p < 0.01, ***p < 0.001.

To further characterize the cytoprotective and pro-regenerative effects of TCM-Gel, we examined changes in markers associated with ferroptosis in hGFs. Ferroptosis is an iron-dependent form of regulated cell death that can influence bone and inflammatory diseases.30,31

At the molecular level, glutathione peroxidase 4 (GPX4) is a core antioxidant enzyme that detoxifies lipid peroxides, whereas the tumor suppressor p53 can promote ferroptosis under specific stress conditions.30 In periodontitis, Porphyromonas gingivalis LPS has been associated with ferroptosis-related changes in hGFs and inflammatory injury.32 These observations provided a rationale for examining ferroptosis-associated marker changes in the present study.

In the present study, LPS altered several ferroptosis-associated markers, including increased expression of p53 and ACSL4 together with reduced GPX4 expression. TCM-Gel attenuated these LPS-associated changes, reducing p53 (~0.85 vs ~1.15 in LPS; P < 0.001; Figure 6H) and FACL4 (~0.95 vs ~1.30 in LPS; P < 0.001; Figure 6K) and restoring GPX4 expression (~1.25 vs ~0.80 in LPS; P < 0.001; Figure 6L), suggesting that modulation of a GPX4-related redox axis may contribute to its cytoprotective effects under inflammatory stress.

TCM-Gel Attenuates Periodontal Inflammation and Alveolar Bone Loss in vivo

We established a murine ligature-induced periodontitis model (Figure 7A and B). H&E staining showed that TCM-Gel reduced inflammatory cell infiltration around the second molar and preserved a more intact periodontal architecture (Figure 7C). Meanwhile, we assessed the in vivo biocompatibility of TCM-Gel by subcutaneous injection into the dorsal region of mice. Tissue samples from the injection sites were harvested after 5 days and examined by H&E staining. At 5 days after subcutaneous injection, tissue architecture was largely preserved, with limited inflammatory-cell infiltration at the tissue-hydrogel interface (Figure 7D). This finding indicates a limited acute local tissue response under the tested conditions. Analysis of micro-CT data showed that local TCM-Gel treatment significantly reduced alveolar bone resorption compared with PBS treatment. Specifically, the CEJ-ABC distances were decreased at both the mesial and distal aspects of the maxillary second molar (Figure 7E and F), indicating protection against bone loss.

Figure 7.

A composite scientific figure with oral photos, a day timeline, micrographs, MicroCT and bar charts. A) Two intraoral photos labeled, Periodontitis and TCM-Gel, each showing a ligature around a molar and surrounding gum. B) A horizontal timeline labeled, Day, with tick marks at 0, 2, 4, 6, 8, 10, 12, 14, 16, 18. Symbols above the line mark events labeled, Ligature follow-up examination; Materials smear on the gum around the second molar; Remove the ligature; Sacrifice; Micro CT; Histology. Group labels under the line read, Group 1: Control, Group 2: Ligature plus PBS, Group 3: Ligature plus TCM-Gel. C) Three hematoxylin and eosin micrographs labeled, Control, Periodontitis and TCM-Gel, showing periodontal sections around a molar. A scale bar label reads, 100 micrometer. D) Four hematoxylin and eosin micrographs are arranged in two columns labeled Control and TCM-Gel and two rows labeled 5 times and 20 times; the 5-times images contain boxed regions. Scale bar labels read, 200 micrometer for the 5 times row and 50 micrometer for the 20 times row. E) Three MicroCT slice images labeled, Control, Periodontitis and TCM-Gel, showing the maxilla and molar roots. F) A bar chart with x-axis categories, Control, Periodontitis, TCM-Gel and y-axis label, Bone loss (micrometer), with tick values 0, 100, 200, 300, 400, 500. Bar heights are approximately 100 for Control, approximately 280 for Periodontitis and approximately 170 for TCM-Gel. G) A bar chart with x-axis categories, Control, Periodontitis, TCM-Gel and y-axis label, BV over TV (percent), with tick values 0, 10, 20, 30, 40. Bar heights are approximately 30 for Control, approximately 20 for Periodontitis and approximately 26 for TCM-Gel. H) A bar chart with x-axis categories, Control, Periodontitis, TCM-Gel and y-axis label, Tb. N (1 over millimeter), with tick values 0, 1, 2, 3. Bar heights are approximately 2.3 for Control, approximately 1.8 for Periodontitis and approximately 2.0 for TCM-Gel. I) A bar chart with x-axis categories, Control, Periodontitis, TCM-Gel and y-axis label, Tb. Sp (millimeter), with tick values 0.0, 0.1, 0.2, 0.3, 0.4, 0.5. Bar heights are approximately 0.30 for Control, approximately 0.35 for Periodontitis and approximately 0.31 for TCM-Gel. J) A bar chart with x-axis categories, Control, Periodontitis, TCM-Gel and y-axis label, Tb. Th (millimeter), with tick values 0.00, 0.05, 0.10, 0.15, 0.20. Bar heights are approximately 0.14 for Control, approximately 0.11 for Periodontitis and approximately 0.13 for TCM-Gel. K) TRAP-stained periodontal micrographs arranged in three columns labeled, Control, Periodontitis and TCM-Gel. The top row is labeled, 10 times, with a boxed region in each column and a scale bar label, 100 micrometer. The bottom row is labeled, 40 times, showing higher magnification views with a scale bar label, 20 micrometer. L) IL6 immunohistochemistry micrographs arranged in three columns labeled, Control, Periodontitis and TCM-Gel. The top row is labeled, 10 times, with a boxed region in each column and a scale bar label, 100 micrometer. The bottom row is labeled, 40 times, showing higher magnification views with a scale bar label, 20 micrometer. M) A bar chart with x-axis categories, Control, Periodontitis, TCM-Gel and y-axis label, TRAP positive cells, with tick values 0, 10, 20, 30, 40, 50. Bar heights are approximately 5 for Control, approximately 32 for Periodontitis and approximately 18 for TCM-Gel. N) A bar chart with x-axis categories, Control, Periodontitis, TCM-Gel and y-axis label, Relative OD of IL6, with tick values 0, 10, 20, 30. Bar heights are approximately 1 for Control, approximately 20 for Periodontitis and approximately 8 for TCM-Gel.

TCM-Gel attenuates inflammatory alveolar bone loss and improves trabecular microarchitecture in ligature-induced periodontitis. (A) Stereomicroscopic images of the ligature-induced periodontitis model and the local application of TCM-Gel. (B) Experimental timeline: mice were initially allocated to healthy control or ligature cohorts; healthy controls were not ligated, and ligature-cohort mice were randomized on day 6 to Ligature + PBS or Ligature + TCM-Gel, followed by ligature removal on day 12 and continued treatment until day 18. (C) Representative H&E-stained periodontal sections. (D) H&E assessment of the local tissue response 5 days after subcutaneous TCM-Gel injection. (E) Representative 3D micro-CT reconstructed images of the maxilla. (F) Quantification of alveolar bone loss by measuring the distance from the cementoenamel junction to the alveolar bone crest. (G–J) Micro-CT trabecular parameters within a standardized ROI: BV/TV, Tb.N, Tb.Sp, and Tb.Th. (K) TRAP staining of periodontal tissues for the identification of osteoclasts. (L) Immunohistochemical (IHC) staining for the pro-inflammatory cytokine IL-6 in periodontal tissues. (M) Quantification of the number of TRAP-positive cells. (N) Semi-quantitative analysis of IL-6 expression. In (D), black dotted-line boxes in the 5× images indicate the regions shown at 20× below. In (K) and (L), black dotted-line boxes in the 10× images indicate the corresponding regions shown at 40× below. Groups: Control, Ligature + PBS (Periodontitis), and Ligature + TCM-Gel (Treatment). For the subcutaneous local tissue-response assessment in (D), n = 3 mice. For the periodontitis groups in (A–C) and (E–N), n = 5 mice per group. Scale bars are indicated in each micrograph. Data are presented as mean ± SD. One-way ANOVA with Tukey’s post hoc test was used for statistical analysis. ns, not significant; *p < 0.05, **p < 0.01, ***p < 0.001.

Three-dimensional micro-CT morphometric analysis provided quantitative measures of alveolar bone mass and trabecular microarchitecture (Figure 7G–J). Compared with the healthy control group, BV/TV was reduced in the periodontitis group (29.21 ± 0.98% vs 19.10 ± 2.47%), whereas TCM-Gel treatment increased BV/TV to 25.42 ± 0.44%. Tb.N decreased in the periodontitis group (2.21 ± 0.12 mm−1 vs 1.77 ± 0.11 mm−1) and increased to 1.98 ± 0.09 mm−1 after treatment. Tb.Sp increased in periodontitis (0.29 ± 0.01 mm vs 0.34 ± 0.01 mm) and was reduced to 0.31 ± 0.01 mm after TCM-Gel treatment. Tb.Th decreased in periodontitis (0.13 ± 0.01 mm vs 0.11 ± 0.01 mm) and returned to 0.13 ± 0.01 mm after treatment. These parameters, together with the CEJ-ABC measurement, show that TCM-Gel attenuated inflammation-associated alveolar bone loss and improved trabecular microarchitecture in vivo.

TRAP staining showed fewer TRAP-positive multinucleated cells in the TCM-Gel group, with corresponding quantification of TRAP-positive cells (Figure 7K, M), indicating reduced osteoclast activity. IHC analysis also showed lower IL-6 staining in the TCM-Gel group than in the periodontitis model group, reaching levels comparable to the healthy control group (Figure 7L, N). These findings support reduced local inflammation and osteoclast activity after TCM-Gel treatment.

In vivo Effects of TCM-Gel are Associated with Macrophage Markers and SIRT1 Expression

Macrophage-marker expression in periodontal tissues was assessed by IHC. Compared with the periodontitis model group, TCM-Gel treatment reduced CD80 staining and increased CD206 staining, with corresponding changes in their semiquantitative analyses (Figure 8A, B, E, F), consistent with a shift toward a pro-resolving macrophage profile. Endomucin (EMCN) staining and its semiquantitative analysis also showed increased expression in the TCM-Gel group (Figure 8C, G), consistent with an angiogenesis-supportive tissue environment.

Figure 8.

Composite infographic with IHC micrographs and bar charts for CD80, CD206, EMCN and SIRT1 in 3 groups. A) CD80 immunohistochemistry micrographs for Control, Periodontitis and TCM Gel. Top row shows 10 times views with a boxed region in each; scale bar label reads 100 micrometer. Bottom row shows the corresponding 40 times views; scale bar label reads 20 micrometer. B) CD206 immunohistochemistry micrographs for Control, Periodontitis and TCM Gel. Same layout as A) with 10 times views above and 40 times views below, boxed regions in the 10 times views and scale bar labels 100 micrometer and 20 micrometer. C) EMCN immunohistochemistry micrographs for Control, Periodontitis and TCM Gel. Same layout as A) with 10 times views above and 40 times views below, boxed regions in the 10 times views and scale bar labels 100 micrometer and 20 micrometer. D) SIRT1 immunohistochemistry micrographs for Control, Periodontitis and TCM Gel. Same layout as A) with 10 times views above and 40 times views below, boxed regions in the 10 times views and scale bar labels 100 micrometer and 20 micrometer. E) A bar chart of Relative IOD of CD80. X axis categories: Control, Periodontitis, TCM Gel. Y axis label: Relative IOD of CD80, unit not shown. Y axis tick labels shown: 0, 10, 20, 30, 40. Bar heights: Control near 0; Periodontitis about 26; TCM Gel about 10. Significance brackets: Control to Periodontitis marked with three asterisk; Periodontitis to TCM Gel marked with three asterisk; Control to TCM Gel marked with three asterisk. F) A bar chart of Relative IOD of CD206. X axis categories: Control, Periodontitis, TCM Gel. Y axis label: Relative IOD of CD206, unit not shown. Y axis tick labels shown: 0, 10, 20, 30, 40. Bar heights: Control near 0; Periodontitis about 7; TCM Gel about 25. Significance brackets: Control to Periodontitis marked with two asterisk; Periodontitis to TCM Gel marked with three asterisk; Control to TCM Gel marked with three asterisk. G) A bar chart of Relative IOD of EMCN. X axis categories: Control, Periodontitis, TCM Gel. Y axis label: Relative IOD of EMCN, unit not shown. Y axis tick labels shown: 0, 10, 20, 30, 40, 50. Bar heights: Control near 0; Periodontitis about 6; TCM Gel about 28. Significance brackets: Control to Periodontitis labeled ns; Periodontitis to TCM Gel marked with three asterisk; Control to TCM Gel marked with three asterisk. H) A bar chart of Relative IOD of SIRT1. X axis categories: Control, Periodontitis, TCM Gel. Y axis label: Relative IOD of SIRT1, unit not shown. Y axis tick labels shown: 0, 20, 40, 60, 80. Bar heights: Control near 0; Periodontitis about 15; TCM Gel about 50. Significance brackets: Control to Periodontitis marked with one asterisk; Periodontitis to TCM Gel marked with three asterisk; Control to TCM Gel marked with three asterisk.

In vivo effects of TCM-Gel are associated with macrophage-marker expression, EMCN staining, and SIRT1 expression. (A) Representative CD80 IHC staining and (E) corresponding semiquantitative analysis. (B) Representative CD206 IHC staining and (F) corresponding semiquantitative analysis. (C) Representative EMCN IHC staining and (G) corresponding semiquantitative analysis. (D) Representative SIRT1 IHC staining and (H) corresponding semiquantitative analysis. Black dotted-line boxes in the representative histological images at 10× magnification indicate the regions shown at higher magnification (40×) below. Groups: Control, Ligature + PBS (Periodontitis), and Ligature + TCM-Gel (Treatment). n = 5 mice per group. Scale bars are indicated in each micrograph. Data are presented as mean ± SD. One-way ANOVA with Tukey’s post hoc test was used. ns, not significant; *p < 0.05, **p < 0.01, ***p < 0.001.

IHC analysis further showed increased SIRT1 staining and semiquantitative expression after TCM-Gel treatment compared with the periodontitis model group (Figure 8D, H). This finding was consistent with the SIRT1-associated transcriptional changes observed in vitro and supports an association between local treatment, macrophage-marker remodeling, and mitochondrial regulatory signaling.

Discussion

This study developed an injectable and photocurable GelMA-based nanozyme-polyphenol hydrogel and examined how its macromolecular architecture relates to local redox regulation and periodontal protection. GelMA formed the hydrated network, whereas tannic acid-functionalized COS-molybdate nanocomplexes and proanthocyanidins supplied pH-dependent component availability, radical-scavenging activity, and catalase-like H2O2 decomposition with oxygen generation. In macrophages, these physicochemical functions were accompanied by reduced oxidative stress, improved mitochondrial indices, and a CD206-high/CD80-low pro-resolving phenotype. Changes in SIRT1-associated signaling and proteomic enrichment of mitochondrial processes were consistent with the observed immunometabolic remodeling.32,33 In vivo, these responses coincided with reduced inflammation, osteoclast activity, and alveolar bone loss. In this system, the GelMA network served as a local carrier for nanozyme and polyphenol components with antioxidant and oxygen-generating activities.

Many periodontal biomaterials primarily provide structural support or deliver a single growth or immunoregulatory cue.33,34 TCM-Gel instead combines a photocrosslinked GelMA network with functional nanocomplexes and polyphenols. Tannic acid and proanthocyanidins contribute radical-scavenging and inflammation-modulating activity,20 whereas molybdenum-associated cues may contribute to the observed mitochondrial and macrophage immunometabolic changes.15 Although several biomaterials have been reported to shift macrophage-marker expression,5 the present study extends the analysis to mitochondrial membrane potential, mitochondrial abundance, respiratory-chain transcripts, and proteomic remodeling.14,35,36 Catalase-like H2O2 decomposition additionally produced dissolved oxygen, a function relevant to emerging oxygen-generating periodontal hydrogels.36 The combination of a locally retained GelMA network, antioxidant activity, and oxygen-generating catalysis may therefore provide a physicochemical basis for the observed changes in redox status, mitochondrial indices, and immune-related responses.

Targeting mitochondrial function may provide an upstream approach to the immunometabolic circuitry that sustains periodontitis. Macrophage phenotype is closely linked to metabolic programming, with inflammatory macrophage states relying mainly on glycolysis and pro-resolving states requiring efficient oxidative phosphorylation.37,38 In periodontitis, persistent oxidative stress can damage mitochondrial structure and dynamics, leading to accumulation of dysfunctional mitochondria.13 These mitochondria may restrict metabolic adaptation and perpetuate inflammation through mitochondrial stress signals.13,14 In the present study, molybdenum-associated cues delivered by TCM-Gel were associated with increased SIRT1 and respiratory-chain transcripts, mitochondrial membrane potential, and mitochondrial abundance.15,16 Proteomic analysis further showed enrichment of protein sets related to mitochondrial gene expression and the mitochondrial matrix, whereas inflammatory-response-related sets were negatively enriched.

The material also affected non-immune periodontal cells. In hGFs, TCM-Gel reduced oxidative injury, attenuated ferroptosis-associated marker changes, and increased mineralization, ALP, and RUNX2. These findings indicate that TCM-Gel treatment was associated with cytoprotective and pro-osteogenic changes in hGFs. In vivo, increased EMCN expression accompanied the observed improvement in periodontal tissue outcomes, while micro-CT and histology demonstrated reduced alveolar bone resorption, inflammatory infiltration, and osteoclast activity. Because macrophage mitochondrial dysfunction contributes to several chronic inflammatory disorders,13,14 the broader design concept of local redox-oxygenation control within a biological macromolecular scaffold may be transferable to other applications.39,40 Such translation will nevertheless require disease-specific optimization of composition, degradation, and dosing.

Several limitations should be considered. First, efficacy was evaluated primarily in a murine periodontitis model, and differences in periodontal anatomy, immune complexity, and disease progression require validation in larger-animal models before clinical translation. Second, the in vivo experiment did not include a Ligature + GelMA/vehicle control that matched the GelMA concentration, photoinitiator, injection volume, light exposure, and treatment schedule. Therefore, the present in vivo data cannot separate the independent contributions of the TCM nanocomplex, the GelMA matrix, and the photocuring procedure. Third, the current data are consistent with SIRT1-associated mitochondrial regulatory changes, whereas the broader SIRT1/PGC-1α regulatory framework remains a mechanistic hypothesis; PGC-1α was not directly measured and no pathway-specific intervention was performed. Fourth, the ferroptosis-related interpretation is based on changes in p53, ACSL4, and GPX4; direct measurements of lipid peroxidation, iron-dependent cell death, and pharmacological rescue experiments were not performed. Fifth, each in vivo group contained five mice and the observation period was relatively short, which may limit the precision of effect estimates and the interpretation of long-term efficacy. Finally, the enhanced release observed at pH 8.5 reflects a comparative in vitro property and should not be interpreted as evidence that all periodontal lesions are alkaline or that pH 8.5 is the direct in vivo trigger. Future work should evaluate mitochondrial dynamics, mitophagy, relevant metabolites, direct ferroptosis-related events, matched GelMA-only controls, longer follow-up, and material designs that can be tuned for enhanced release under acidic conditions.

Conclusions

TCM-Gel combined a locally retained GelMA network with nanoscale molybdate-polyphenol components and was associated with reduced oxidative stress, improved macrophage mitochondrial indices, a pro-resolving macrophage-marker profile, and attenuation of periodontal bone loss. These findings support further evaluation of nanozyme-polyphenol hydrogels as local nanomedicine platforms for periodontal therapy.

Funding Statement

This work was supported by the Science Research Cultivation Program of Stomatological Hospital, Southern Medical University (PY2023031 to Jiayu Lin; PY2025036 to Yueshan Zhou), the Guangdong Provincial Medical Research Fund (B2026245 to Jiayu Lin; B2026208 to Yueshan Zhou), the National Administration of Traditional Chinese Medicine Comprehensive Reform Pilot Zone Science and Technology Collaborative Project (GZY-KJS-GD-2025-046 to Xiuhong Huang), and the National Natural Science Foundation of China (82505616 to Liqin Zheng). The funders had no role in study design, data collection, analysis or interpretation, manuscript preparation, or the decision to submit the article for publication.

Abbreviations

ABTS, 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid); ALP, alkaline phosphatase; CAT, catalase; CEJ-ABC, cementoenamel junction to alveolar bone crest; CMO, chitosan molybdate; COS, chitosan oligosaccharide; DCFH-DA, 2′,7′-dichlorofluorescin diacetate; DPPH, 2,2-diphenyl-1-picrylhydrazyl; EDS, energy-dispersive X-ray spectroscopy; EMCN, endomucin; ETC, electron transport chain; FE-SEM, field-emission scanning electron microscopy; GelMA, gelatin methacryloyl; GPX4, glutathione peroxidase 4; hGF, human gingival fibroblast; HPLC, high-performance liquid chromatography; IHC, immunohistochemistry; LAP, lithium phenyl-2,4,6-trimethylbenzoylphosphinate; LPS, lipopolysaccharide; MMP, mitochondrial membrane potential; PBS, phosphate-buffered saline; PGC-1α, peroxisome proliferator-activated receptor-gamma coactivator-1α; qRT-PCR, quantitative real-time polymerase chain reaction; ROS, reactive oxygen species; RUNX2, runt-related transcription factor 2; SIRT1, sirtuin 1; SOD, superoxide dismutase; TA, tannic acid; TCM, tannic acid-functionalized chitosan oligosaccharide-molybdate nanocomplex; TEM, transmission electron microscopy; TRAP, tartrate-resistant acid phosphatase.

Data Sharing Statement

The data supporting the findings of this study are contained within the article and its Supporting Information. Additional raw data generated during the current study are available from Xiuhong Huang, the corresponding author, upon reasonable request.

Ethics Approval and Informed Consent

All animal experiments were conducted at the animal facility of Guangzhou Ruige Biotechnology Co., Ltd. and were approved by the Institutional Animal Care and Use Committee of Ruige Biotechnology (Approval No. 20240501-001). The procedures were performed in accordance with institutional animal welfare requirements and applicable veterinary guidelines. Isoflurane inhalation anesthesia and gradual-fill CO2 euthanasia followed by cervical dislocation were performed as described in the Materials and Methods section and were consistent with the AVMA Guidelines for the Euthanasia of Animals. Human gingival fibroblasts were obtained from a commercial cell bank (Procell, catalog No. CP-H240). No human participants were recruited, and no identifiable human data or tissues were collected; therefore, informed consent was not required. Consent for Publication: Not applicable.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Disclosure

The authors report no conflicts of interest in this work.

References

  • 1.Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 2017;3:17038. doi: 10.1038/nrdp.2017.38 [DOI] [PubMed] [Google Scholar]
  • 2.Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol. 2021;21:426–21. doi: 10.1038/s41577-020-00488-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Marruganti C, Suvan JE, D’Aiuto F. Periodontitis and metabolic diseases (diabetes and obesity): tackling multimorbidity. Periodontol 2000. 2023;91:56–75. doi: 10.1111/prd.12536 [DOI] [PubMed] [Google Scholar]
  • 4.Schenkein HA, Papapanou PN, Genco R, Sanz M. Mechanisms underlying the association between periodontitis and atherosclerotic disease. Periodontol 2000. 2020;83:90–106. doi: 10.1111/prd.12304 [DOI] [PubMed] [Google Scholar]
  • 5.Yang B, Pang X, Li Z, Chen Z, Wang Y. Immunomodulation in the treatment of periodontitis: progress and perspectives. Front Immunol. 2021;12:781378. doi: 10.3389/fimmu.2021.781378 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Xia Z, Zhao B, Xiang J, et al. Injectable pH-responsive hydrogel adapted to gingival crevicular fluid microenvironment for periodontitis therapy. ACS Appl Mater Interfaces. 2025;17:31357–31367. doi: 10.1021/acsami.5c02776 [DOI] [PubMed] [Google Scholar]
  • 7.Qi H, Wang B, Wang M, Xie H, Chen C. A pH/ROS-responsive antioxidative and antimicrobial GelMA hydrogel for on-demand drug delivery and enhanced osteogenic differentiation in vitro. Int J Pharm. 2024;657:124134. doi: 10.1016/j.ijpharm.2024.124134 [DOI] [PubMed] [Google Scholar]
  • 8.Sun X, Gao J, Meng X, Lu X, Zhang L, Chen R. Polarized macrophages in periodontitis: characteristics, function, and molecular signaling. Front Immunol. 2021;12:763334. doi: 10.3389/fimmu.2021.763334 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Brown BN, Sicari BM, Badylak SF. Rethinking regenerative medicine: a macrophage-centered approach. Front Immunol. 2014;5:510. doi: 10.3389/fimmu.2014.00510 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Peng S, Fu H, Li R, et al. A new direction in periodontitis treatment: biomaterial-mediated macrophage immunotherapy. J Nanobiotechnol. 2024;22(1):359. doi: 10.1186/s12951-024-02592-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Mills EL, Kelly B, O’Neill LAJ. Mitochondria are the powerhouses of immunity. Nat Immunol. 2017;18:488–498. doi: 10.1038/ni.3704 [DOI] [PubMed] [Google Scholar]
  • 12.Tian Z, Wang X, Chen S, Guo Z, Di J, Xiang C. Mitochondria-targeted biomaterials regulating macrophage polarization open new perspectives for disease treatment. Int J Nanomed. 2025;20:1509–1528. doi: 10.2147/IJN.S505591 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Galván-Peña S, O’Neill LAJ. Metabolic reprograming in macrophage polarization. Front Immunol. 2014;5:420. doi: 10.3389/fimmu.2014.00420 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.den Bossche J V, Baardman J, Otto NA, et al. Mitochondrial dysfunction prevents repolarization of inflammatory macrophages. Cell Rep. 2016;17:684–696. doi: 10.1016/j.celrep.2016.09.008 [DOI] [PubMed] [Google Scholar]
  • 15.He XT, Li X, Zhang M, et al. Role of molybdenum in material immunomodulation and periodontal wound healing: targeting immunometabolism and mitochondrial function for macrophage modulation. Biomaterials. 2022;283:121439. doi: 10.1016/j.biomaterials.2022.121439 [DOI] [PubMed] [Google Scholar]
  • 16.Huang X, Zheng L, Zhou Y, et al. Controllable adaptive molybdate-oligosaccharide nanoparticles regulate M2 macrophage mitochondrial function and promote angiogenesis via PI3K/HIF-1α/VEGF pathway to accelerate diabetic wound healing. Adv Healthc Mater. 2024;13:e2302256. doi: 10.1002/adhm.202302256 [DOI] [PubMed] [Google Scholar]
  • 17.Zou T, Liang Y, Kang J, et al. Oxygen enrichment mediated by calcium peroxide loaded gelatin methacrylate hydrogel eradicates periodontal biofilms. Int J Biol Macromol. 2024;265(Pt 1):130868. doi: 10.1016/j.ijbiomac.2024.130868 [DOI] [PubMed] [Google Scholar]
  • 18.McCranie EK, Bachmann BO. Bioactive oligosaccharide natural products. Nat Prod Rep. 2014;31:1026–1042. doi: 10.1039/c3np70128J [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Naveed M, Phil L, Sohail M, et al. Chitosan oligosaccharide (COS): an overview. Int J Biol Macromol. 2019;129:827–843. doi: 10.1016/j.ijbiomac.2019.01.192 [DOI] [PubMed] [Google Scholar]
  • 20.Sivanantham A, Pattarayan D, Rajasekar N, et al. Tannic acid prevents macrophage-induced pro-fibrotic response in lung epithelial cells via suppressing TLR4-mediated macrophage polarization. Inflamm Res. 2019;68:1011–1024. doi: 10.1007/s00011-019-01282-4 [DOI] [PubMed] [Google Scholar]
  • 21.Liu Y, Li T, Sun M, et al. ZIF-8-modified multifunctional injectable photopolymerizable GelMA hydrogel for the treatment of periodontitis. Acta Biomater. 2022;146:37–48. doi: 10.1016/j.actbio.2022.03.046 [DOI] [PubMed] [Google Scholar]
  • 22.Chen J, Guan X, Chen L, et al. Customized hydrogel system for the spatiotemporal sequential treatment of periodontitis propelled by ZEB1. Adv Sci. 2025;12:e2503338. doi: 10.1002/advs.202503338 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Griffiths HR, Gao D, Pararasa C. Redox regulation in metabolic programming and inflammation. Redox Biol. 2017;12:50–57. doi: 10.1016/j.redox.2017.01.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Brand MD, Nicholls DG. Assessing mitochondrial dysfunction in cells. Biochem J. 2011;435:297–312. doi: 10.1042/bj20110162 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Averill-Bates DA. The antioxidant glutathione. Vitam Horm. 2023;121:109–141. doi: 10.1016/bs.vh.2022.09.002 [DOI] [PubMed] [Google Scholar]
  • 26.Jin SW, Lee GH, Kim JY, et al. Effect of porcine whole blood protein hydrolysate on slow-twitch muscle fiber expression and mitochondrial biogenesis via the AMPK/SIRT1 pathway. Int J Mol Sci. 2022;23:1229. doi: 10.3390/ijms23031229 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Mitchell P. Coupling of phosphorylation to electron and hydrogen transfer by a chemiosmotic type of mechanism. Nature. 1961;191:144–148. doi: 10.1038/191144a0 [DOI] [PubMed] [Google Scholar]
  • 28.Vercellino I, Sazanov LA. The assembly, regulation and function of the mitochondrial respiratory chain. Nat Rev Mol Cell Biol. 2022;23:141–161. doi: 10.1038/s41580-021-00415-0 [DOI] [PubMed] [Google Scholar]
  • 29.Goffart S, Wiesner RJ. Regulation and co-ordination of nuclear gene expression during mitochondrial biogenesis. Exp Physiol. 2003;88:33–40. doi: 10.1113/eph8802500 [DOI] [PubMed] [Google Scholar]
  • 30.Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266–282. doi: 10.1038/s41580-020-00324-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Li J, Cao F, Yin HL, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11:88. doi: 10.1038/s41419-020-2298-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Qiao S, Li B, Cai Q, et al. Involvement of ferroptosis in Porphyromonas gingivalis lipopolysaccharide-stimulated periodontitis in vitro and in vivo. Oral Dis. 2023;29:3571–3582. doi: 10.1111/odi.14292 [DOI] [PubMed] [Google Scholar]
  • 33.Pearce EL, Pearce EJ. Metabolic pathways in immune cell activation and quiescence. Immunity. 2013;38:633–643. doi: 10.1016/j.immuni.2013.04.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.De Lauretis A, Øvrebø Ø, Romandini M, et al. From basic science to clinical practice: a review of current periodontal/mucogingival regenerative biomaterials. Adv Sci. 2024;11(17):2308848. doi: 10.1002/advs.202308848 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Zhu Y, Xiu Z, Jiang X, et al. Injectable hydrogels with ROS-triggered drug release enable the co-delivery of antibacterial agent and anti-inflammatory nanoparticle for periodontitis treatment. J Nanobiotechnol. 2025;23:205. doi: 10.1186/s12951-025-03275-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Newland B, Baeger M, Eigel D, et al. Oxygen-producing gellan gum hydrogels for dual delivery of either oxygen or peroxide with doxorubicin. ACS Biomater Sci Eng. 2017;3(5):787–792. doi: 10.1021/acsbiomaterials.7b00078 [DOI] [PubMed] [Google Scholar]
  • 37.Chang HC, Guarente L. SIRT1 and other sirtuins in metabolism. Trends Endocrinol Metab. 2014;25:138–145. doi: 10.1016/j.tem.2013.12.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Koo SJ, Garg NJ. Metabolic programming of macrophage functions and pathogens control. Redox Biol. 2019;24:101198. doi: 10.1016/j.redox.2019.101198 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity. 2010;32:593–604. doi: 10.1016/j.immuni.2010.05.007 [DOI] [PubMed] [Google Scholar]
  • 40.Tabas I, Bornfeldt KE. Macrophage phenotype and function in different stages of atherosclerosis. Circ Res. 2016;118:653–667. doi: 10.1161/circresaha.115.306256 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data supporting the findings of this study are contained within the article and its Supporting Information. Additional raw data generated during the current study are available from Xiuhong Huang, the corresponding author, upon reasonable request.


Articles from International Journal of Nanomedicine are provided here courtesy of Dove Press

RESOURCES